Whilst plasma is a minimally invasive sample of choice for biomarker-based testing, the measurement of systemic CXCL10 concentrations could be confounded in certain scenarios (for example, those with an inflammatory component such as rheumatoid arthritis [23]. Here, CXCL10 is linked to rheumatoid arthritis.